Satsuma Pharmaceuticals, Inc. Operating Lease Cost
Satsuma Pharmaceuticals, Inc. reported Operating Lease Cost of $40.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-05-11
- Satsuma Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2023-03-31 was $40.00K, a 2.56% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2022-12-31 was $48.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2022-09-30 was $47.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2022-06-30 was $48.00K.
- Satsuma Pharmaceuticals, Inc. operating lease, cost for fiscal 2022 was $182.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-03-31 | $40.00K 10-Q · filed 2023-05-11 | $88.00K derived: sum of 2 quarters · filed 2023-05-11 | $135.00K derived: sum of 3 quarters · filed 2023-05-11 | $183.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $95.00K derived: sum of 2 quarters · filed 2023-03-28 | $143.00K derived: sum of 3 quarters · filed 2023-03-28 | $182.00K 10-K · filed 2023-03-28 |
| 2022-09-30 | $47.00K 10-Q · filed 2022-11-03 | $95.00K derived: sum of 2 quarters · filed 2022-11-03 | $134.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $48.00K 10-Q · filed 2022-08-09 | $87.00K 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | $39.00K 10-Q · filed 2023-05-11 |